Fumihiko Kanai

11.2k total citations · 2 hit papers
158 papers, 8.7k citations indexed

About

Fumihiko Kanai is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Fumihiko Kanai has authored 158 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 61 papers in Hepatology and 37 papers in Epidemiology. Recurrent topics in Fumihiko Kanai's work include Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Liver Disease Diagnosis and Treatment (28 papers) and Hepatitis C virus research (15 papers). Fumihiko Kanai is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Liver Disease Diagnosis and Treatment (28 papers) and Hepatitis C virus research (15 papers). Fumihiko Kanai collaborates with scholars based in Japan, United States and United Kingdom. Fumihiko Kanai's co-authors include Masao Omata, Takao Kawabe, Tsuneo Ikenoue, Naoya Kato, Yasushi Shiratori, Keisuke Tateishi, Yasuo Tanaka, Michael B. Yaffe, Shuichiro Shiina and Jun Imamura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Fumihiko Kanai

158 papers receiving 8.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins

2000 625 citations Fumihiko Kanai et al. The EMBO Journal profile →
The PX domains of p47phox and p40phox bind to lipid products of PI(3)K

2001 509 citations Fumihiko Kanai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fumihiko Kanai Japan	54	4.3k	2.1k	1.8k	1.8k	1.4k	158	8.7k
Sandrine Imbeaud France	43	4.2k 1.0×	1.9k 0.9×	1.4k 0.8×	1.3k 0.7×	1.1k 0.7×	90	7.8k
Ronnie T.P. Poon Hong Kong	55	3.1k 0.7×	4.0k 2.0×	2.0k 1.1×	2.0k 1.1×	1.5k 1.0×	106	8.4k
Thomas Longerich Germany	45	3.3k 0.8×	1.7k 0.8×	1.9k 1.0×	1.4k 0.8×	911 0.6×	205	7.4k
Louis Libbrecht Belgium	48	2.1k 0.5×	3.5k 1.7×	2.1k 1.2×	2.0k 1.1×	2.3k 1.6×	170	7.5k
Hiroyuki Marusawa Japan	43	2.9k 0.7×	2.0k 1.0×	2.4k 1.4×	1.5k 0.8×	1.3k 0.9×	160	7.1k
Taro Yamashita Japan	46	4.5k 1.0×	2.7k 1.3×	1.8k 1.0×	2.8k 1.6×	1.1k 0.7×	240	9.4k
Massimo Roncalli Italy	59	3.2k 0.7×	2.7k 1.3×	2.1k 1.2×	4.7k 2.7×	1.8k 1.2×	228	11.5k
Marshonna Forgues United States	36	5.5k 1.3×	2.0k 1.0×	1.3k 0.7×	2.5k 1.4×	816 0.6×	51	9.4k
Anuradha Budhu United States	36	5.7k 1.3×	1.8k 0.9×	971 0.5×	2.5k 1.4×	862 0.6×	58	9.3k
Charles Balabaud France	55	4.7k 1.1×	5.6k 2.7×	3.5k 1.9×	2.4k 1.4×	3.4k 2.4×	238	12.5k

Countries citing papers authored by Fumihiko Kanai

Since Specialization

Citations

This map shows the geographic impact of Fumihiko Kanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihiko Kanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihiko Kanai more than expected).

Fields of papers citing papers by Fumihiko Kanai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumihiko Kanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihiko Kanai. The network helps show where Fumihiko Kanai may publish in the future.

Co-authorship network of co-authors of Fumihiko Kanai

This figure shows the co-authorship network connecting the top 25 collaborators of Fumihiko Kanai. A scholar is included among the top collaborators of Fumihiko Kanai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumihiko Kanai. Fumihiko Kanai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kudo, Masatoshi, Kazuomi Ueshima, Yasutaka Chiba, et al.. (2019). Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial. Liver Cancer. 8(6). 505–519. 12 indexed citations

Ogasawara, Sadahisa, Tetsuhiro Chiba, Tenyu Motoyama, et al.. (2016). Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma. PLoS ONE. 11(9). e0163119–e0163119. 5 indexed citations

Maruyama, Hitoshi, Masanori Takahashi, Tadashi Sekimoto, et al.. (2012). Heterogeneity of Microbubble Accumulation: A Novel Approach to Discriminate Between Well-Differentiated Hepatocellular Carcinomas and Regenerative Nodules. Ultrasound in Medicine & Biology. 38(3). 383–388. 9 indexed citations

Kanai, Fumihiko, Ryosuke Tateishi, Yasuo Tanaka, et al.. (2009). Preliminary dose finding study of Erythropoietin for Peginterferon/Ribavirin-induced anemia in Japanese patients with hepatitis C. Kanzo. 50(8). 427–436. 1 indexed citations

Imamura, Jun, Ryosuke Tateishi, Shuichiro Shiina, et al.. (2008). Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma. The American Journal of Gastroenterology. 103(12). 3057–3062. 81 indexed citations

Ohta, Miki, Motoko Seto, Hideaki Ijichi, et al.. (2008). Decreased Expression of the RAS-GTPase Activating Protein RASAL1 Is Associated With Colorectal Tumor Progression. Gastroenterology. 136(1). 206–216. 74 indexed citations

Masuzaki, Ryota, Ryosuke Tateishi, Haruhiko Yoshida, et al.. (2008). Comparison of Liver Biopsy and Transient Elastography based on Clinical Relevance. SHILAP Revista de lepidopterología. 22(9). 753–757. 21 indexed citations

Ikenoue, Tsuneo, Fumihiko Kanai, Yohko Hikiba, et al.. (2005). Functional consequences of mutations in a putative Akt phosphorylation motif of B‐raf in human cancers. Molecular Carcinogenesis. 43(1). 59–63. 13 indexed citations

Tanaka, Yasuo, Fumihiko Kanai, Tohru Ichimura, et al.. (2005). The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene. 25(4). 633–642. 83 indexed citations

10.

Tanaka, Yasuo, Fumihiko Kanai, Takayuki Kawakami, et al.. (2004). Interaction of the hepatitis B virus X protein (HBx) with heat shock protein 60 enhances HBx-mediated apoptosis. Biochemical and Biophysical Research Communications. 318(2). 461–469. 78 indexed citations

11.

Chen, Ping, Lakshmanan K. Iyer, Chang Hun Lee, et al.. (2002). Determination of Substrate Motifs for Human Chk1 and hCds1/Chk2 by the Oriented Peptide Library Approach. Journal of Biological Chemistry. 277(18). 16102–16115. 124 indexed citations

12.

Ijichi, Hideaki, Tsuneo Ikenoue, Naoya Kato, et al.. (2001). Systematic Analysis of the TGF-β-Smad Signaling Pathway in Gastrointestinal Cancer Cells. Biochemical and Biophysical Research Communications. 289(2). 350–357. 47 indexed citations

13.

Kanai, Fumihiko, et al.. (2000). TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins. The EMBO Journal. 19(24). 6778–6791. 625 indexed citations breakdown →

14.

Ohashi, Makoto, Fumihiko Kanai, Hideki Ueno, et al.. (1999). Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo. Gut. 44(3). 366–371. 40 indexed citations

15.

Maeda, Shingo, K. Ogura, Hisako Yoshida, et al.. (1998). Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut. 42(3). 338–343. 214 indexed citations

16.

Ogura, K., Fumihiko Kanai, Shin Maeda, et al.. (1997). High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan. Gut. 41(4). 463–468. 37 indexed citations

17.

Maeda, Shin, Fumihiko Kanai, Keiji Ogura, et al.. (1997). High Seropositivity of Anti-CagA Antibody in Helicobacter pylori-Infected Patients Irrelevant to Peptic Ulcers and Normal Mucosa in Japan. Digestive Diseases and Sciences. 42(9). 1841–1847. 63 indexed citations

18.

Kanai, Fumihiko, Yasushi Shiratori, Yoko Yoshida, et al.. (1996). Gene Therapy for α–Fetoprotein–Producing Human Hepatoma Cells by Adenovirus–Mediated Transfer of the Herpes Simplex Virus Thymidine Kinase Gene. Hepatology. 23(6). 1359–1368. 101 indexed citations

19.

Shiratori, Yasushi, Shuichiro Shiina, Masatoshi Imamura, et al.. (1995). Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology. 22(4). 1027–1033. 239 indexed citations

20.

Yamazaki, Z, Yoshikazu Fujimori, Itoe Iizuka, et al.. (1984). Effect of immunoadsorption on patient with rheumatoid arthritis or SLE.. PubMed. 30. 211–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact